Perspective · 10 Sep 2026
Conference abstractPublished 15 Oct 2013
NLRP3-deficient mice have enhanced neutrophil apoptosis and suppressed inflammatory response to hyperoxia-induced acute lung injury
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Inspiration of high concentration of oxygen, a therapy for acute lung injury (ALI) could unexpectedly lead to reactive oxygen species (ROS) production and hyperoxia-induced acute lung injury (HALI). Nucleotide-binding domain and leucine-rich repeat PYD containing protein 3 (NLRP3) senses the ROS, triggering inflammasome activation and interleukin-1beta (IL-1β) production and secretion. However, the role of NLRP3 inflammasome in HALI is unclear. The aim of this study is to determine the effect of NLRP3 gene deletion on inflammatory response and cell death in the lungs of hyperoxic mice. In this study, WT and NLRP3 -/- mice were exposed to 100% O2 for 48-72 hrs. Bronchoalveolar lavage (BAL) fluid and lung tissues were examined for proinflammatory cytokines and lung inflammation. Conditioned media from NLRP3 silenced THP-1 cells were added to human neutrophils to examine neutrophil survival and apoptosis. Results showed that Hyperoxia induced lung pathological score were suppressed in NLRP3 -/- mice when compared to WT mice. Hyperoxia-induced recruitment of inflammatory cells and elevation of IL-1β, TNFα and MCP-1 are attenuated in NLRP3 -/- mice. NLRP3 deletion decreased lung epithelial cell death, caspase-3 levels and suppressed NFκB levels when compared to wild type controls. Neutrophils co incubated with NLRP3 silenced THP- 1 conditioned medium displayed enhanced neutrophil apoptosis when compared to controls. Taken together, this research demonstrates for the first time that NLRP3-deficient mice have enhanced neutrophil apoptosis and a suppressed inflammatory response to HALI.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Narasaiah Kolliputi”
